Literature DB >> 33232879

Gender and race interact to influence survival disparities in head and neck cancer.

Angela L Mazul1, Akash N Naik2, Kevin Y Zhan2, Katelyn O Stepan3, Matthew O Old2, Stephen Y Kang2, Erik R Nakken3, Sidharth V Puram4.   

Abstract

Gender and race disparities in head and neck squamous cell carcinoma (HSNCC) survival are independently well documented, but no prior studies have examined the joint effect of these factors on HSNCC outcomes. We aim to comprehensively estimate the effect of gender and race on overall survival in HNSCC. We constructed a retrospective cohort from the National Cancer Database for primary HNSCC of the larynx, hypopharynx, oral cavity, and oropharynx from 2010 to 2015. We used Kaplan-Meier curves and Cox proportional hazards regressions to calculate hazard ratios adjusting for treatment type, age, insurance, staging classifications, and comorbidities. Oral cavity cancer was significantly more common among Hispanic and White females compared to other sites. Female non-oropharyngeal HNSCC cases had better five-year overall survival than males (56.3% versus 54.4%, respectively), though Black females (52.8%) had poorer survival than both White (56.2%) and Hispanic (57.9%) males. There were significant differences in oropharyngeal cancer by HPV status. Notably, Black females with HPV-positive oropharyngeal OPSCC had far worse survival than any other race and gender group. These results persisted even when adjusting for potential mediating factors. Clearly gender is a significant prognosticator for HNSCC and has meaningful interactions with race. The distinct site distributions across gender and race reveal important insights into HNSCC among females. Taking into account these gender disparities while considering race is essential to providing appropriate care to head and neck patients and accurately counselling these individuals on prognosis and outcomes.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gender; Head and Neck Cancer; Health Care Disparities; Race; Survival

Year:  2020        PMID: 33232879     DOI: 10.1016/j.oraloncology.2020.105093

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access.

Authors:  Marcus A Florez; Jan O Kemnade; Nan Chen; Wendy Du; Anita L Sabichi; Daniel Y Wang; Quillan Huang; Courtney N Miller-Chism; Aparna Jotwani; Albert C Chen; David Hernandez; Vlad C Sandulache
Journal:  Cancer Res Commun       Date:  2022-07-26

2.  Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.

Authors:  Steven F Powell; Miroslaw Mazurczak; Elie G Dib; Jonathon S Bleeker; Louis H Geeraerts; Matthew Tinguely; Michele M Lohr; Steven C McGraw; Ashley W Jensen; Christie A Ellison; Lora J Black; Susan E Puumala; Valerie J Reed; W Keith Miskimins; John H Lee; William C Spanos
Journal:  Invest New Drugs       Date:  2022-03-21       Impact factor: 3.651

3.  Genetic Variation in the ZNF208 Gene at rs8103163 and rs7248488 Is Associated With Laryngeal Cancer in the Northwestern Chinese Han Male.

Authors:  Shiyang Wang; Xiulin Wen; Ruimin Zhao; Yanxia Bai
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

4.  Development and validation of a nomogram to predict cancer-specific survival in patients with hypopharyngeal squamous cell carcinoma treated with primary surgery.

Authors:  Ke Wang; Xia Xu; Ruotao Xiao; Danyi Du; Luqi Wang; Hanqing Zhang; Zehong Lv; Xiangping Li; Gang Li
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  Trends in Treatment of Head and Neck Cancer in Germany: A Diagnosis-Related-Groups-Based Nationwide Analysis, 2005-2018.

Authors:  Isabel Hermanns; Rafat Ziadat; Peter Schlattmann; Orlando Guntinas-Lichius
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

Review 6.  The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.

Authors:  Steven F Powell; Lexi Vu; William C Spanos; Dohun Pyeon
Journal:  Cancers (Basel)       Date:  2021-10-17       Impact factor: 6.575

Review 7.  An equity-based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma.

Authors:  Elizabeth A Noyes; Ciersten A Burks; Andrew R Larson; Daniel G Deschler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-09

8.  Adherence to a priori-Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models.

Authors:  Christian A Maino Vieytes; Sandra L Rodriguez-Zas; Zeynep Madak-Erdogan; Rebecca L Smith; Katie R Zarins; Gregory T Wolf; Laura S Rozek; Alison M Mondul; Anna E Arthur
Journal:  Front Nutr       Date:  2022-04-25

9.  Sex-Related Differences in Outcomes for Oropharyngeal Squamous Cell Carcinoma by HPV Status.

Authors:  Derek D Kao; Rocco M Ferrandino; Deborah C Marshall; Tinaye Mutetwa; Brett Miles; Joshua M Bauml; Keith M Sigel
Journal:  Int J Otolaryngol       Date:  2022-05-02

Review 10.  Bias and Class Imbalance in Oncologic Data-Towards Inclusive and Transferrable AI in Large Scale Oncology Data Sets.

Authors:  Erdal Tasci; Ying Zhuge; Kevin Camphausen; Andra V Krauze
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.